Latest Press Releases

Patient Centricity in Pharma: Best Practices for Building Trust

Patient centricity is now recognized as one of the key values in the pharmaceutical business, changing both the research and development of new drugs as well as their clinical trials and treatment. For example, a recent Deloitte report revealed that ...

KFSHRC Jeddah Performs the First Fully Robotic Liver Transplant in the Western Region

JEDDAH, Saudi Arabia, Dec. 11, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) in Jeddah successfully performed the first robotic liver transplant in the Western Region on a 23-year-old man suffering from ...

WeightWatchers Unveils Next-Gen Program With AI-Powered App Features

NEW YORK, Dec. 10, 2024 (GLOBE NEWSWIRE) -- WeightWatchers (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) today announced the launch of its innovative next-gen program, introducing advanced features designed to make weight management ...

CEPI and Accumulus Synergy Team up to Enhance Information Equity and Accelerate Access to Vaccines

OSLO, Norway and BURLINGAME, Calif., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Accumulus Synergy’s innovative cloud-based data-sharing platform could accelerate access to vaccines and other health technologies by enabling multi-country regulatory ...

RenaissThera Closes Seed Funding to Drive AI-Powered Therapies for Cardio-Metabolic Diseases

BENGALURU, India, Dec. 10, 2024 (GLOBE NEWSWIRE) -- RenaissThera Private Limited (“RenaissThera”), a pioneering Bengaluru-based biotechnology company, has successfully closed its seed funding round backed by angel investors. This funding will ...

AiViva Biopharma Receives FDA Clearance to Administer AIV001 in Facial Skin by Intradermal Injection for Nonmelanoma Skin Cancer

AIV001 is currently in development for evaluation in Superficial and Nodular Superficial Basal Cell Carcinoma (sBCC and nBCC) COSA MESA, Calif., Dec. 09, 2024 (GLOBE NEWSWIRE) -- AiViva Biopharma Inc., a clinical-stage biotechnology company, ...

SpliceBio Announces U.S. FDA IND Clearance of SB-007 to Commence Phase 1/2 Clinical Study in Patients with Stargardt Disease

PR Newswire BARCELONA, Spain, Dec. 12, 2024 BARCELONA, Spain, Dec. 12, 2024 /PRNewswire/ -- SpliceBio, a genetic medicines company pioneering Protein Splicing to address diseases caused by mutations in large genes, today announced that the ...

Neuraxpharm and Pharmathen enter into strategic co-development agreement to develop long-acting injectable therapies

PR Newswire BARCELONA, Spain, DÜSSELDORF, Germany, and ATHENS, Greece, Dec. 12, 2024 New therapies will allow patients greater choice and flexibility in the control of CNS disorders BARCELONA, Spain, DÜSSELDORF, Germany, and ATHENS, ...

KIND Presents Preclinical Results of AND017 in Animal Models of Sickle Cell Disease (SCD), Myelodysplastic Syndromes (MDS), and ß-Thalassemia at the 66th American Society of Hematology Meeting and Exposition and Announces FDA Authorization of Investigational New Drug (IND) Application for AND017 for Clinical Trial in Sickle Cell Disease (SCD)

PR Newswire SAN FRANCISCO, Dec. 12, 2024 SAN FRANCISCO, Dec. 12, 2024 /PRNewswire/ -- Kind Pharmaceutical ("Hangzhou Andao Pharmaceutical Ltd. and Kind Pharmaceuticals LLC"), a clinical-stage biopharmaceutical company focused on developing ...

Patient Centricity in Pharma: Best Practices for Building Trust

Patient centricity is now recognized as one of the key values in the pharmaceutical business, changing both the research and development of new drugs as well as their clinical trials and treatment. For example, a recent Deloitte report revealed that ...

A2A Pharmaceuticals, Inc. Announces Phase 1 Clinical Trial Advancements in TACC3 Inhibition Program Targeting Multiple Cancers

PR Newswire NEW YORK, Dec. 11, 2024 NEW YORK, Dec. 11, 2024 /PRNewswire/ -- A2A Pharmaceuticals, Inc. ("A2A or "the company"), a clinical-stage pioneering biopharmaceutical company focused on developing innovative cancer therapies, today ...

Heparin Market to Grow by USD 3.34 Billion (2024-2028), Driven by Coagulation Disorder Prevalence and AI Impacting Market Trends - Technavio

PR Newswire NEW YORK, Dec. 11, 2024 NEW YORK, Dec. 11, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape - The global heparin market size is estimated to grow by USD 3.34 billion from 2024-2028, according to Technavio. The ...

T-cell Malignancies Market Dynamics: Key Insights on Acute Lymphocytic Leukemia, Peripheral T-cell Lymphoma, Cutaneous T-cell Lymphoma, Anaplastic Large Cell Lymphoma, and Adult T-cell Leukemia/Lymphoma | DelveInsight

PR Newswire LAS VEGAS, Dec. 11, 2024 T-cell malignancies account for about 10-15% of all lymphoid malignancies, and their treatment often involves chemotherapy, immunotherapy, or stem cell transplantation. These cancers can be particularly ...

Tampa General Hospital Recognized as Top Hospital for Maternity Care by U.S. News & World Report

PR Newswire TAMPA, Fla., Dec. 11, 2024 The region's only university-affiliated academic health system is acknowledged for its continued commitment to providing exceptional maternity, childbirth and postpartum care. TAMPA, Fla., Dec. 11, ...

Ready. Set. Food! and ObvioHealth Complete Recruitment for Infant Food Allergy Study

PR Newswire NEW YORK, Dec. 11, 2024 NEW YORK, Dec. 11, 2024 /PRNewswire/ -- Ready. Set. Food!, a leader in early allergen introduction solutions, and ObvioHealth, a global leader in digital clinical trial solutions, are proud to announce the ...

A chronic issue - disease rates climbing among young Canadians

Canada NewsWire TORONTO, Dec. 11, 2024 New report finds drug claims for chronic diseases like diabetes and high blood pressure on the rise TORONTO, Dec. 11, 2024 /CNW/ - Chronic diseases don't discriminate when it comes to age. A new ...

Revolutionary Robotic Surgery Combines Dual-System Technologies for Groundbreaking Prostate Procedure

PR Newswire DALLAS, Dec. 11, 2024 Surgery utilizes Levita MARS Platform and its Dynamic Magnetic Positioning™ technology and Da Vinci Single Port Robotic System to deliver unprecedented precision and set a new standard for minimally invasive ...

Pelvital Launches Next-Generation FDA-Cleared Flyte® System, Treating All Severities of Stress Urinary Incontinence

PR Newswire EAGAN, Minn., Dec. 11, 2024 The new Flyte App and Provider Portal offer enhanced tracking and personalization for women suffering from mild to severe SUI, improving care outcomes and provider-patient collaboration EAGAN, ...

GNT Pharma Reports Significant Improvements in Stroke Patients Treated with its pioneering Phase 3 Drug Nelonemdaz™

PR Newswire SEOUL, South Korea, Dec. 11, 2024 ** IND submitted to the FDA showing significantly improved patient condition when administered within 70 minutes of arrival at the Emergency Room ** *Multinational Phase 3 Clinical Trial ...

Students Stressed and Anxious While Higher Education Funding Questions Loom

PR Newswire FORT WORTH, Texas, Dec. 11, 2024 TimelyCare survey highlights mental health and financial challenges impacting college and university students. FORT WORTH, Texas, Dec. 11, 2024 /PRNewswire/ -- A recent survey by TimelyCare, ...

NeuroSense Receives Positive FDA Feedback on Phase 3 Study Design for PrimeC

PR Newswire CAMBRIDGE, Mass., Dec. 11, 2024 CAMBRIDGE, Mass., Dec. 11, 2024 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe ...

Dynocardia has received a $1 million NSF grant to enhance their unique computer vision-based motion-correction technology and expand the applications of its ViTrack® continuous non-invasive blood pressure (cNIBP) monitor

PR Newswire CAMBRIDGE, Mass., Dec. 11, 2024 Dynocardia's proprietary computer-vision technology effectively identifies and compensates for movement artifacts. Overcoming these artifacts has long been a significant challenge in accurately ...

Capstan Medical Secures $110M to Bring First-of-its-Kind Robotics Technology to Heart Disease Patients

PR Newswire SANTA CRUZ, Calif., Dec. 11, 2024 Led by Eclipse, the round will further allow the company to bring the benefits of robotics to one of the few remaining untouched areas of medicine and structural heart SANTA CRUZ, Calif., ...

9amHealth Becomes First Virtual Cardiometabolic Care Provider to Achieve CDC's Highest Recognition for Diabetes Prevention Program

PR Newswire SAN DIEGO, Dec. 11, 2024 Cohort Outperforms National Averages, Setting a New Standard for Diabetes Prevention for Employers and Health Plans SAN DIEGO, Dec. 11, 2024 /PRNewswire/ -- 9amHealth, the leading virtual ...

Genetesis Launches CardioFlux Membership Program to Revolutionize Preventive Cardiac Care and Eliminate Heart Disease

PR Newswire MASON, Ohio, Dec. 11, 2024 Proactive, personalized monitoring of myocardial fitness at regular intervals, powered by MCG technology, represents paradigm shift in the prevention of heart disease City of Mason's Biohealth ...

BGIS Announces New $1 Million Commitment to Support Youth Mental Health Across Canada through Kids Help Phone's Cam's Kids Program

Canada NewsWire TORONTO, Dec. 11, 2024 TORONTO, Dec. 11, 2024 /CNW/ - Kids Help Phone is thrilled to announce a transformational investment from BGIS, the leading Canadian facilities management company, in support of youth mental health ...

Tips for Looking After Aging Parents During the Busy Holiday Season

PR Newswire FORT LAUDERDALE, Fla., Dec. 11, 2024 FORT LAUDERDALE, Fla., Dec. 11, 2024 /PRNewswire/ -- Even during the hectic holiday season leading to Christmas and New Year's there's always extra help to give the best possible care for ...

Lilly's Imlunestrant, an Oral SERD, Significantly Improved Progression-Free Survival as Monotherapy and in Combination with Verzenio® (abemaciclib) in Patients with ER+, HER2- Advanced Breast Cancer

PR Newswire INDIANAPOLIS, Dec. 11, 2024 As monotherapy, imlunestrant significantly reduced the risk of progression or death by 38% compared to standard endocrine therapy (ET) in patients with ESR1 mutations As combination therapy, ...

NCCN Announces Funding for a Prostate Cancer Research Project

PR Newswire PLYMOUTH MEETING, Pa., Dec. 11, 2024 The National Comprehensive Cancer Network's Oncology Research Program's grant will advance scientific knowledge of hematologic toxicity of PARPi in the treatment of patients with prostate ...

Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed Publication

PR Newswire NEW YORK, Dec. 11, 2024 Study demonstrates outstanding clinical utility including an exceptionally high 85% patient compliance with referral to confirmatory upper endoscopy following EsoGuard esophageal precancer testing NEW ...

Kazia Therapeutics to Present Data Highlighting Synergistic Activity Between Paxalisib and Immunotherapy in Immunotherapy-Resistant Triple Negative Breast Cancer Model at the San Antonio Breast Cancer Symposium

PR Newswire SYDNEY, Dec. 11, 2024 SYDNEY, Dec. 11, 2024 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development, announced that data from two abstracts will be presented at the San Antonio Breast ...

Florida Cancer Specialists & Research Institute Advancing Breast Cancer Research

PR Newswire FORT MYERS, Fla., Dec. 11, 2024 Results of first in-human trials highlighted at global symposium FORT MYERS, Fla., Dec. 11, 2024 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) medical oncologists ...

New Patient-Reported Outcome Insights from Target RWE: NASH-CHECK Reveals Stability Over Time and Worse Scores Among Those with Decompensated Cirrhosis of Patients with MASLD

PR Newswire DURHAM, N.C., Dec. 11, 2024 DURHAM, N.C., Dec. 11, 2024 /PRNewswire/ -- Target RWE, real-world evidence leader, shared two studies at The Liver Meeting 2024 that revealed insights on the NASH-CHECK1 patient-reported outcome ...

Expression Therapeutics Announces Promising Phase 1 Results for Groundbreaking Hemophilia A Gene Therapy at ASH

PR Newswire ATLANTA, Dec. 11, 2024 ATLANTA, Dec. 11, 2024 /PRNewswire/ -- Expression Therapeutics, Inc., has presented the results of a Phase 1 clinical trial for its novel lentiviral vector-based gene therapy — ET3 — for hemophilia A at the ...

ADC Therapeutics Announces Positive Initial Data from LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Bispecific Antibody in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma

PR Newswire LAUSANNE, Switzerland, Dec. 11, 2024 ZYNLONTA in combination with glofitamab demonstrated clinically meaningful benefit with 94% best ORR and 72% CR rate Safety data show no dose-limiting toxicities (DLTs), no high-grade ...

SystImmune, Inc. to Present Updated BL-B01D1 Data in Breast Cancer at SABCS Congress 2024

PR Newswire REDMOND, Wash., Dec. 11, 2024 - Updated safety & efficacy data in locally advanced or metastatic breast cancer patients will be presented from a phase 1 clinical study evaluating BL-B01D1, an EGFRxHER3 bispecific topoisomerase ...

Latest Press Releases

Premium Press Releases »

Patient Centricity in Pharma: Best Practices for Building Trust

KFSHRC Jeddah Performs the First Fully Robotic Liver Transplant in the Western Region

WeightWatchers Unveils Next-Gen Program With AI-Powered App Features

CEPI and Accumulus Synergy Team up to Enhance Information Equity and Accelerate Access to Vaccines

RenaissThera Closes Seed Funding to Drive AI-Powered Therapies for Cardio-Metabolic Diseases

AiViva Biopharma Receives FDA Clearance to Administer AIV001 in Facial Skin by Intradermal Injection for Nonmelanoma Skin Cancer

Press Releases »

SpliceBio Announces U.S. FDA IND Clearance of SB-007 to Commence Phase 1/2 Clinical Study in Patients with Stargardt Disease

Neuraxpharm and Pharmathen enter into strategic co-development agreement to develop long-acting injectable therapies

Patient Centricity in Pharma: Best Practices for Building Trust

A2A Pharmaceuticals, Inc. Announces Phase 1 Clinical Trial Advancements in TACC3 Inhibition Program Targeting Multiple Cancers

Heparin Market to Grow by USD 3.34 Billion (2024-2028), Driven by Coagulation Disorder Prevalence and AI Impacting Market Trends - Technavio

T-cell Malignancies Market Dynamics: Key Insights on Acute Lymphocytic Leukemia, Peripheral T-cell Lymphoma, Cutaneous T-cell Lymphoma, Anaplastic Large Cell Lymphoma, and Adult T-cell Leukemia/Lymphoma | DelveInsight

Tampa General Hospital Recognized as Top Hospital for Maternity Care by U.S. News & World Report

Ready. Set. Food! and ObvioHealth Complete Recruitment for Infant Food Allergy Study

A chronic issue - disease rates climbing among young Canadians

Revolutionary Robotic Surgery Combines Dual-System Technologies for Groundbreaking Prostate Procedure

Pelvital Launches Next-Generation FDA-Cleared Flyte® System, Treating All Severities of Stress Urinary Incontinence

GNT Pharma Reports Significant Improvements in Stroke Patients Treated with its pioneering Phase 3 Drug Nelonemdaz™

Students Stressed and Anxious While Higher Education Funding Questions Loom

NeuroSense Receives Positive FDA Feedback on Phase 3 Study Design for PrimeC

Dynocardia has received a $1 million NSF grant to enhance their unique computer vision-based motion-correction technology and expand the applications of its ViTrack® continuous non-invasive blood pressure (cNIBP) monitor

Capstan Medical Secures $110M to Bring First-of-its-Kind Robotics Technology to Heart Disease Patients

9amHealth Becomes First Virtual Cardiometabolic Care Provider to Achieve CDC's Highest Recognition for Diabetes Prevention Program

Genetesis Launches CardioFlux Membership Program to Revolutionize Preventive Cardiac Care and Eliminate Heart Disease

BGIS Announces New $1 Million Commitment to Support Youth Mental Health Across Canada through Kids Help Phone's Cam's Kids Program

Tips for Looking After Aging Parents During the Busy Holiday Season

Lilly's Imlunestrant, an Oral SERD, Significantly Improved Progression-Free Survival as Monotherapy and in Combination with Verzenio® (abemaciclib) in Patients with ER+, HER2- Advanced Breast Cancer

NCCN Announces Funding for a Prostate Cancer Research Project

Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed Publication

Kazia Therapeutics to Present Data Highlighting Synergistic Activity Between Paxalisib and Immunotherapy in Immunotherapy-Resistant Triple Negative Breast Cancer Model at the San Antonio Breast Cancer Symposium

Florida Cancer Specialists & Research Institute Advancing Breast Cancer Research

New Patient-Reported Outcome Insights from Target RWE: NASH-CHECK Reveals Stability Over Time and Worse Scores Among Those with Decompensated Cirrhosis of Patients with MASLD

Expression Therapeutics Announces Promising Phase 1 Results for Groundbreaking Hemophilia A Gene Therapy at ASH

ADC Therapeutics Announces Positive Initial Data from LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Bispecific Antibody in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma

SystImmune, Inc. to Present Updated BL-B01D1 Data in Breast Cancer at SABCS Congress 2024

Medindia Newsletters